- Home
- MIST vs GNTA Comparison
MIST vs GNTA Comparison
Compare MIST & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIST | GNTA |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | Canada | Italy |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 34.0M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | MIST | GNTA |
|---|---|---|
| Price | $2.08 | $1.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 9.9M | 101.9K |
| Earning Date | 11-12-2025 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.63 | $1.28 |
| 52 Week High | $3.06 | $10.00 |
Technical Indicators
Market Signals| Indicator | MIST | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 44.26 | 37.90 |
| Support Level | $1.98 | $1.32 |
| Resistance Level | $2.10 | $1.70 |
| Average True Range (ATR) | 0.15 | 0.16 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 24.54 | 33.33 |
Price Performance
Historical ComparisonAbout MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.